SteveCleves
Well-Known Member
For those of you that haven't seen it, it seems like the FDA is stopping compounding pharmacies from offering most peptides.
"FDA would consider taking action against a compounder or outsourcing facility for compounding drug products with bulk drug substances listed in category 2 under its general enforcement policies."
BACK TO THE UNDERGROUND YOU GO!!!!
Not sure what this ultimately means as it seems most people get their peptides from "research chemical" suppliers.
What I am curious is what this is going to do to the bro-TRT clinics that with the removal of Anavar, and now Peptides are going to see their profit margins shrink even more.
Substances in Compounding that May Present Significant Safety Risks
Category 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act
www.fda.gov
"FDA would consider taking action against a compounder or outsourcing facility for compounding drug products with bulk drug substances listed in category 2 under its general enforcement policies."
BACK TO THE UNDERGROUND YOU GO!!!!
Not sure what this ultimately means as it seems most people get their peptides from "research chemical" suppliers.
What I am curious is what this is going to do to the bro-TRT clinics that with the removal of Anavar, and now Peptides are going to see their profit margins shrink even more.